Ocular side-effects of urological pharmacy.
Ritchie
Robert W
RW
Department of Urology, Churchill Hospital, Oxford, UK. robritchie@doctors.org.uk
Lindfield
Daniel M
DM
Lockyer
Charles Richard William
CR
Adamson
Andrew
A
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D000328:Adult; D016587:Antimutagenic Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D018783:Impotence, Vasculogenic / Q000188:drug therapy; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D016587:Antimutagenic Agents; D000970:Antineoplastic Agents; D010726:Phosphodiesterase Inhibitors